Orally administered Endoxifen is a new therapeutic agent for breast cancer

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham et al. · JNCI Journal of the National Cancer Institute · 1998 · 5.5K citations · Full text

Tamoxifen for early breast cancer: an overview of the randomised trials

The Lancet · 1998 · 4.1K citations

Breast Oncology, Early Breast Cancer, Medicine +10

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Michael C. Alley, Dominic A. Scudiero, Anne Monks et al. · PubMed · 1988 · 3.1K citations

Chemoprevention Strategy, Tumor Biology, Microculture Tetrazolium Assay +16

CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment

Yan Jin, Zeruesenay Desta, Vered Stearns et al. · JNCI Journal of the National Cancer Institute · 2005 · 931 citations · Full text

Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine

Vered Stearns · JNCI Journal of the National Cancer Institute · 2003 · 835 citations · Full text